Clinical Research Coordinator - Southwest Oncology Group @ University of Washington Cancer Center
Christina Derleth's Education
Vanderbilt University School of Medicine
Master of Science
2009 - 2011
University of Washington School of Medicine
Doctor of Medicine (Medicine)
2000 - 2004
University of Washington
Bachelors (Molecular Biology)
1994 - 1998
University of Washington
(Biology)
Christina Derleth's Skills
Clinical Research
Clinical Trials
Medicine
Oncology
Cancer
Christina Derleth's Summary
Christina Derleth, based in Edmonds, Washington, United States, is currently a Executive Medical Director and Global Development Lead Enfortumab Vedotin at Seattle Genetics, bringing experience from previous roles at Seattle Genetics, Genentech and Vanderbilt University. Christina Derleth holds a 2009 - 2011 Master of Science @ Vanderbilt University School of Medicine. With a robust skill set that includes Clinical Research, Clinical Trials, Medicine, Oncology, Cancer and more, Christina Derleth contributes valuable insights to the industry. Christina Derleth has 1 email on RocketReach.